Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay

Rheumatology

Volumn 48, Issue 12, 2009, Pages 1570-1574

  Satoh, Takashi ^a   Ishikawa, Osamu ^b   Ihn, Hironobu ^c   Endo, Hirahito ^d   Kawaguchi, Yasushi ^e   Sasaki, Tetsuo ^f   Goto, Daisuke ^g   Takahashi, Kazuo ^h   Takahashi, Hiroki ⁱ   Misaki, Yoshikata ^j   Mimori, Tsuneyo ^k   Muro, Yoshinao ^l   Yazawa, Norihito ^j   Sato, Shinichi ^m   Takehara, Kazuhiko ⁿ   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f International University of Health and Welfare   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

^h YOKOHAMA CITY UNIVERSITY   (Japan)

ⁱ SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k KYOTO UNIVERSITY   (Japan)

^l NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m NAGASAKI UNIVERSITY   (Japan)

ⁿ KANAZAWA UNIVERSITY   (Japan)

more..

Author keywords

Autoantibody; ELISA; Renal crisis; RNA polymerase; SSc severity scale; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA TOPOISOMERASE ANTIBODY; ENZYME ANTIBODY; RNA POLYMERASE III ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOPRECIPITATION; JAPANESE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN DISEASE; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 75649094810     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep290     Document Type: Article

References (19)

1. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35: 35-42.
2. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83.
3. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003;5:80-93.
4. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest 1993;91:1399-404.
5. Okano Y, Steen VD, Medsger TA Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993;119:1005-13.
6. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 1998;37: 15-20.
7. Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clin Exp Immunol 1999;117:395-402.
8. Bardoni A, Rossi P, Salvini R, Bobbio-Pallavicini F, Caporali R, Montecucco C. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 2003;21:301-6.
9. Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. Q J Med 2007;100:485-94.
10. Kuwana M, Kimura K, Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzymelinked immunosorbent assay. Arthritis Rheum 2002;46:2742-7.
11. Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA Jr. Enzymelinked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 2005;52:2425-32.
12. Masi AT, Rodnan GP, Medsger TA Jr et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
13. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in fortyeight patients. Arthritis Rheum 2000;43:444-51.
14. Medsger TA Jr, Silman AJ, Steen VD et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
15. Codullo V, Morozzi G, Bardoni A et al. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol 2007;25:373-7.
16. Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol 2007;34: 1528-34.
17. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6.
18. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104-9.
19. Chang M, Wang RJ, Yangco DT, Sharp GC, Komatireddy GR, Hoffman RW. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol 1998;89:71-8.